Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
2476
Pillai O, Kumar N, Dey CS, Borkute S, Nagalingam S and Panchagnula R. Transdermal iontophoresis of insulin Part 1: A study on the issues associated with the use of platinum electrodes on rat skin Journal of Pharmacy and Pharmacology 2003, 55, 1505-1513.
2477
Ramachandran U, Kumar S and Chawla HPS. A mild and efficient method for racemization of α-amino esters Organic Preparations and Procedures International 2003, 35, 542-545.
2478
Rao KVR, Pakhale SP and Singh S. A film approach for the stabilization of gelatin preparations against cross-linking Pharmaceutical Technology 2003, 27, 54-62.
2479
Ray A, Hector RE, Roy N, Song JH, Berkner KL and Runge KW. Sir3p phosphorylation by the Slt2p pathway effects redistribution of silencing function and shortened lifespan Nature Genetics 2003, 33, 522-526.
2480
Roy A, Bhattacharyya MS, Kumar LR, Chawla HPS and Banerjee UC. Microbial reduction of 1-acetonapthone: a highly efficient process for multigram synthesis of S(-)-1-(1'-napthyl) ethanol Enzyme and Microbial Technology 2003, 33, 576-580.
2481
Roy N and Agarwal S. Therapeutic Protein Production - An Overview Future Drug Discovery 2003, .
2482
Sankar R, Sharda N and Singh S. Behavior of decomposition of rifampicin in the presence of isoniazid in the pH range 1-3 Drug Development and Industrial Pharmacy 2003, 29, 733-738.
2483
Singal P and Singh PP. Induction of colony-stimulating factors by Leishmania donovani amastigote soluble antigens Journal of Parasitic Diseases 2003, 27, 85-93.
2484
Singal P, Kinhikar AG, Singh S and Singh PP. Neuroimmunomodulatory effects of morphine in Leishmania donovani-infected hamsters NeuroImmunoModulation 2003, 10, 261-269.
2485
Singh S and Mohan B. A pilot stability study on four-drug fixed-dose combination anti-tuberculosis products International Journal of Tuberculosis and Lung Disease 2003, 7, 298-303.
2486
Sood A and Panchagnula R. Design of controlled release delivery systems using a modified pharmacokinetic approach: a case study for drugs having a short elimination half-life and a narrow therapeutic index International Journal of Pharmaceutics 2003, 261, 27-41.
2487
Sukhpreet and Tiwari P. Indian Journal of Hospital Pharmacy 2003, 40, 148-153.
2488
Tambwekar KR, Kakariya RB and Garg S. A validated high performance liquid chromatographic method for analysis of nicotine in pure form and from formulations Journal of Pharmaceutical and Biomedical Analysis 2003, 32, 441-450.
2489
Thomas NS and Panchagnula R. Combination strategies to enhance transdermal permeation of zidovudine (AZT) Die Pharmazie 2003, 58, 895-898.
2490
Thomas NS and Panchagnula R. Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action European Journal of Pharmaceutical Sciences 2003, 18, 71-79.
2491
Vangapandu S, Sachdeva S, Jain M, Singh S, Singh PP, Kaul CL and Jain R. 8-Quinolinamines and their pro prodrug conjugates as potent blood-schizontocidal antimalarial agents Bioorganic & Medicinal Chemistry 2003, 11, 4557-4568.
2492
Verma RK, Kaushal AM and Garg S. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology International Journal of Pharmaceutics 2003, 263, 24-9.
2493
Agrawal S, Kaur KJ, Singh I, Bhade SR, Kaul CL and Panchagnula R. Assessment of bioequivalence of rifampicin, isoniazid and pyrazinamide in a four drug fixed dose combination with separate formulations at the same dose levels International Journal of Pharmaceutics 2002, 233, 169-177.
2494
Agrawal S, Singh I, Kaur KJ, Bhade SR, Kaul CL and Panchagnula R. Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs separate formulations International Journal of Clinical Pharmacology and Therapeutics 2002, 40, 474-481.
2495
Anjaneyulu M and Ramarao P. Studies on gastrointestinal tract functional changes in diabetic animals Methods and Findings in Experimental and Clinical Pharmacology 2002, 24, 71-75.
2496
Batra N, Singh J, Banerjee UC, Patnaik PR and Sobti RC. Production and characterization of a thermostable beta-galactosidase from Bacillus coagulans RCS3 Biotechnology and applied biochemistry 2002, 36, 6-1.
2497
Bharatam PV, Moudgil R and Kaur D. Lewis Donor and Acceptor Interactions of Silylenes: A Theoretical Study Organometallics 2002, 21, 3683-3690.
2498
Chakraborti AK, Nayak MK and Sharma L. Diphenyl disulfide and sodium in NMP as an efficient protocol for in situ generation of thiophenolate anion: selective deprotection of aryl alkyl ethers and alkyl/aryl esters under nonhydrolytic conditions Journal of Organic Chemistry 2002, 67, 1776-1780.
2499
Chakraborti AK, Sharma L and Nayak MK. Demand-based thiolate anion generation under virtually neutral conditions: The influence of steric and electronic factors on chemo- and regioselective cleavage of aryl alkyl ethers Journal of Organic Chemistry 2002, 67, 6406-6414.
2500
Chakraborti AK, Sharma L and Nayak MK. Influence of Hydrogen Bonding in the Activation of Nucleophiles: PhSH-(Catalytic) KF in N-Methyl-2-pyrrolidone as an Efficient Protocol for Selective Cleavage of Alkyl/Aryl Esters and Aryl Alkyl Ethers under Nonhydrolytic and Neutral Conditions Journal of Organic Chemistry 2002, 67, 2541-2547.
2501
Desiraju G, Gopalakrishnan B, Jetti R, Nagaraju A, Raveendra D, Sarma J, Sobhia ME and Thilagavathi R. Computer-Aided design of selective COX-2 inhibitors: Comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-Diarylimidazole derivatives Journal of Medicinal Chemistry 2002, 45, 4847-4857.
2502
Gandhi R, Pillai O, Thilagavathi R, Gopalakrishnan B, Kaul CL and Panchagnula R. Characterization of Azithromycin hydrates European Journal of Pharmaceutical Sciences 2002, 16, 175-184.
2503
Garg A, Aggarwal D, Garg S and Singla AK. Spreading of semi-solid formulations: an update Pharmaceutical Technology 2002, Sep, 84-105.
2504
Garg S, Vermani K, Kohli G, Kandarapu R, Tambwekar K, Garg A, Waller DP and Zaneveld LJD. Survey of vaginal formulations available on the Indian market: physicochemical characterization of selected products International Journal of Pharmaceutical Medicine 2002, 16, 141-152.
2505
Goel HL and Dey CS. Focal adhesion kinase tyrosine phosphorylation is associated with myogenesis and modulated by insulin Cell Proliferation 2002, 35, 131-142.
2506
Goel HL and Dey CS. Insulin stimulates spreading of skeletal muscle cells involving the activation of focal adhesion kinase, phosphatidylinositol 3-kinase and extracellular signal regulated kinases Journal of Cellular Physiology 2002, 193, 187-198.
2507
Goel HL and Dey CS. Insulin-mediated tyrosine phosphorylation of myosin heavy chain and concomitant enhanced association of C-terminal src kinase during skeletal muscle differentiation Cell Biology International 2002, 26, 557-561.
2508
Goel HL and Dey CS. PKC-regulated myogenesis is associated with increased tyrosine phosphorylation of FAK, Cas, and paxillin, formation of Cas-CRK complex, and JNK activation Differentiation 2002, 70, 257-271.
2509
Goel HL and Dey CS. Role of protein kinase C during insulin mediated skeletal muscle cell spreading Journal of Muscle Research and Cell Motility 2002, 23, 269-277.
2510
Goyal N, Jain SC and Banerjee UC. Comparative Studies on the Microbial Adsorption of Heavy Metals Advances in Environmental Research 2002, 7, 63-71.
2511
Gullapalli S and Ramarao P. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats Neuropharmacology 2002, 42, 467-475.
2512
Gullapalli S and Ramarao P. Regulation of dihydropyridine-sensitive Ca2+ channels during naloxone-induced opioid supersensitivity in rats European Journal of Pharmacology 2002, 451, 271-277.
2513
Gullapalli S and Ramarao P. Role of L-type Ca2+ channels in pertussis toxin induced antagonism of U50,488H analgesia and hypothermia Brain Research 2002, 946, 191-197.
2514
Gullapalli S, Gurumoorthy K, Kaul CL and Ramarao P. Role of L-type Ca2+ channels in attenuated morphine antinociception in streptozotocin-diabetic rats European Journal of Pharmacology 2002, 435, 187-194.
2515
Gullapalli S, Nemmani KVS and Ramarao P. Role of Ca2+ channels on the hypothermic response produced by activation of kappa-opioid receptors Pharmacology Biochemistry and Behavior 2002, 72, 93-99.
2516
Gupta P and Garg S. Recent advances in semisolid dosage forms for dermatological application Pharmaceutical Technology 2002, 3, 144-162.
2517
Ishrath A, Kumar N and Dey CS. Differential activation of ERK and JNK by arsenite in mouse muscle cells Comparative Biochemistry and Physiology Part C 2002, 132, 375-384.
2518
Jadhav HR and Bhutani KK. Antioxidant properties of Indian medicinal plants Phytotherapy Research 2002, 16, 771-773.
2519
Jain AK, Thomas NS and Panchagnula R. Transdermal drug delivery of imipramine hydrochloride.: I. Effect of terpenes Journal of Controlled Release 2002, 79, 93-101.
2520
Jain R, Singh J, Perlman JH and Gershengorn MC. Synthesis and biology of new thyrotropin-releasing hormone (TRH) analogues Bioorganic & Medicinal Chemistry 2002, 10, 189-194.

Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|56|45